Global Neurological Disorder Drugs Market Research Report 2023

Report ID: 1983832 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neurological Disorder Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Antipsychotic
        1.2.3 Hypnotic & Sedative
        1.2.4 Analgesics
        1.2.5 Anticoagulants
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Neurological Disorder Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Neurological Disorder Drugs Market Perspective (2017-2028)
    2.2 Neurological Disorder Drugs Growth Trends by Region
        2.2.1 Neurological Disorder Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Neurological Disorder Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Neurological Disorder Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Neurological Disorder Drugs Market Dynamics
        2.3.1 Neurological Disorder Drugs Industry Trends
        2.3.2 Neurological Disorder Drugs Market Drivers
        2.3.3 Neurological Disorder Drugs Market Challenges
        2.3.4 Neurological Disorder Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Neurological Disorder Drugs Players by Revenue
        3.1.1 Global Top Neurological Disorder Drugs Players by Revenue (2017-2022)
        3.1.2 Global Neurological Disorder Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Neurological Disorder Drugs Revenue
    3.4 Global Neurological Disorder Drugs Market Concentration Ratio
        3.4.1 Global Neurological Disorder Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neurological Disorder Drugs Revenue in 2021
    3.5 Neurological Disorder Drugs Key Players Head office and Area Served
    3.6 Key Players Neurological Disorder Drugs Product Solution and Service
    3.7 Date of Enter into Neurological Disorder Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Neurological Disorder Drugs Breakdown Data by Type
    4.1 Global Neurological Disorder Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Neurological Disorder Drugs Forecasted Market Size by Type (2023-2028)
5 Neurological Disorder Drugs Breakdown Data by Application
    5.1 Global Neurological Disorder Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Neurological Disorder Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Neurological Disorder Drugs Market Size (2017-2028)
    6.2 North America Neurological Disorder Drugs Market Size by Country (2017-2022)
    6.3 North America Neurological Disorder Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Neurological Disorder Drugs Market Size (2017-2028)
    7.2 Europe Neurological Disorder Drugs Market Size by Country (2017-2022)
    7.3 Europe Neurological Disorder Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Neurological Disorder Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Neurological Disorder Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Neurological Disorder Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Neurological Disorder Drugs Market Size (2017-2028)
    9.2 Latin America Neurological Disorder Drugs Market Size by Country (2017-2022)
    9.3 Latin America Neurological Disorder Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Neurological Disorder Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Neurological Disorder Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Neurological Disorder Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Detail
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Neurological Disorder Drugs Introduction
        11.1.4 Novartis Revenue in Neurological Disorder Drugs Business (2017-2022)
        11.1.5 Novartis Recent Development
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Company Detail
        11.2.2 GlaxoSmithKline Business Overview
        11.2.3 GlaxoSmithKline Neurological Disorder Drugs Introduction
        11.2.4 GlaxoSmithKline Revenue in Neurological Disorder Drugs Business (2017-2022)
        11.2.5 GlaxoSmithKline Recent Development
    11.3 Merck & Co.
        11.3.1 Merck & Co. Company Detail
        11.3.2 Merck & Co. Business Overview
        11.3.3 Merck & Co. Neurological Disorder Drugs Introduction
        11.3.4 Merck & Co. Revenue in Neurological Disorder Drugs Business (2017-2022)
        11.3.5 Merck & Co. Recent Development
    11.4 Bayer
        11.4.1 Bayer Company Detail
        11.4.2 Bayer Business Overview
        11.4.3 Bayer Neurological Disorder Drugs Introduction
        11.4.4 Bayer Revenue in Neurological Disorder Drugs Business (2017-2022)
        11.4.5 Bayer Recent Development
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Detail
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca Neurological Disorder Drugs Introduction
        11.5.4 AstraZeneca Revenue in Neurological Disorder Drugs Business (2017-2022)
        11.5.5 AstraZeneca Recent Development
    11.6 Boehringer Ingelheim
        11.6.1 Boehringer Ingelheim Company Detail
        11.6.2 Boehringer Ingelheim Business Overview
        11.6.3 Boehringer Ingelheim Neurological Disorder Drugs Introduction
        11.6.4 Boehringer Ingelheim Revenue in Neurological Disorder Drugs Business (2017-2022)
        11.6.5 Boehringer Ingelheim Recent Development
    11.7 Teva Pharmaceutical
        11.7.1 Teva Pharmaceutical Company Detail
        11.7.2 Teva Pharmaceutical Business Overview
        11.7.3 Teva Pharmaceutical Neurological Disorder Drugs Introduction
        11.7.4 Teva Pharmaceutical Revenue in Neurological Disorder Drugs Business (2017-2022)
        11.7.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Neurological Disorder Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Antipsychotic
    Table 3. Key Players of Hypnotic & Sedative
    Table 4. Key Players of Analgesics
    Table 5. Key Players of Anticoagulants
    Table 6. Key Players of Others
    Table 7. Global Neurological Disorder Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Neurological Disorder Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Neurological Disorder Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Neurological Disorder Drugs Market Share by Region (2017-2022)
    Table 11. Global Neurological Disorder Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Neurological Disorder Drugs Market Share by Region (2023-2028)
    Table 13. Neurological Disorder Drugs Market Trends
    Table 14. Neurological Disorder Drugs Market Drivers
    Table 15. Neurological Disorder Drugs Market Challenges
    Table 16. Neurological Disorder Drugs Market Restraints
    Table 17. Global Neurological Disorder Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Neurological Disorder Drugs Market Share by Players (2017-2022)
    Table 19. Global Top Neurological Disorder Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2021)
    Table 20. Ranking of Global Top Neurological Disorder Drugs Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Neurological Disorder Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Neurological Disorder Drugs Product Solution and Service
    Table 24. Date of Enter into Neurological Disorder Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Neurological Disorder Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Neurological Disorder Drugs Revenue Market Share by Type (2017-2022)
    Table 28. Global Neurological Disorder Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Neurological Disorder Drugs Revenue Market Share by Type (2023-2028)
    Table 30. Global Neurological Disorder Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Neurological Disorder Drugs Revenue Market Share by Application (2017-2022)
    Table 32. Global Neurological Disorder Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Neurological Disorder Drugs Revenue Market Share by Application (2023-2028)
    Table 34. North America Neurological Disorder Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Neurological Disorder Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Neurological Disorder Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Neurological Disorder Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Neurological Disorder Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Neurological Disorder Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Neurological Disorder Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Neurological Disorder Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Neurological Disorder Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Neurological Disorder Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Novartis Company Detail
    Table 45. Novartis Business Overview
    Table 46. Novartis Neurological Disorder Drugs Product
    Table 47. Novartis Revenue in Neurological Disorder Drugs Business (2017-2022) & (US$ Million)
    Table 48. Novartis Recent Development
    Table 49. GlaxoSmithKline Company Detail
    Table 50. GlaxoSmithKline Business Overview
    Table 51. GlaxoSmithKline Neurological Disorder Drugs Product
    Table 52. GlaxoSmithKline Revenue in Neurological Disorder Drugs Business (2017-2022) & (US$ Million)
    Table 53. GlaxoSmithKline Recent Development
    Table 54. Merck & Co. Company Detail
    Table 55. Merck & Co. Business Overview
    Table 56. Merck & Co. Neurological Disorder Drugs Product
    Table 57. Merck & Co. Revenue in Neurological Disorder Drugs Business (2017-2022) & (US$ Million)
    Table 58. Merck & Co. Recent Development
    Table 59. Bayer Company Detail
    Table 60. Bayer Business Overview
    Table 61. Bayer Neurological Disorder Drugs Product
    Table 62. Bayer Revenue in Neurological Disorder Drugs Business (2017-2022) & (US$ Million)
    Table 63. Bayer Recent Development
    Table 64. AstraZeneca Company Detail
    Table 65. AstraZeneca Business Overview
    Table 66. AstraZeneca Neurological Disorder Drugs Product
    Table 67. AstraZeneca Revenue in Neurological Disorder Drugs Business (2017-2022) & (US$ Million)
    Table 68. AstraZeneca Recent Development
    Table 69. Boehringer Ingelheim Company Detail
    Table 70. Boehringer Ingelheim Business Overview
    Table 71. Boehringer Ingelheim Neurological Disorder Drugs Product
    Table 72. Boehringer Ingelheim Revenue in Neurological Disorder Drugs Business (2017-2022) & (US$ Million)
    Table 73. Boehringer Ingelheim Recent Development
    Table 74. Teva Pharmaceutical Company Detail
    Table 75. Teva Pharmaceutical Business Overview
    Table 76. Teva Pharmaceutical Neurological Disorder Drugs Product
    Table 77. Teva Pharmaceutical Revenue in Neurological Disorder Drugs Business (2017-2022) & (US$ Million)
    Table 78. Teva Pharmaceutical Recent Development
    Table 79. Research Programs/Design for This Report
    Table 80. Key Data Information from Secondary Sources
    Table 81. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neurological Disorder Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Antipsychotic Features
    Figure 3. Hypnotic & Sedative Features
    Figure 4. Analgesics Features
    Figure 5. Anticoagulants Features
    Figure 6. Others Features
    Figure 7. Global Neurological Disorder Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Neurological Disorder Drugs Report Years Considered
    Figure 11. Global Neurological Disorder Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Neurological Disorder Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Neurological Disorder Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Neurological Disorder Drugs Market Share by Players in 2021
    Figure 15. Global Top Neurological Disorder Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Neurological Disorder Drugs Revenue in 2021
    Figure 17. North America Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Neurological Disorder Drugs Market Share by Country (2017-2028)
    Figure 19. United States Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Neurological Disorder Drugs Market Share by Country (2017-2028)
    Figure 23. Germany Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Neurological Disorder Drugs Market Share by Region (2017-2028)
    Figure 31. China Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Neurological Disorder Drugs Market Share by Country (2017-2028)
    Figure 39. Mexico Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Neurological Disorder Drugs Market Share by Country (2017-2028)
    Figure 43. Turkey Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Neurological Disorder Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Novartis Revenue Growth Rate in Neurological Disorder Drugs Business (2017-2022)
    Figure 46. GlaxoSmithKline Revenue Growth Rate in Neurological Disorder Drugs Business (2017-2022)
    Figure 47. Merck & Co. Revenue Growth Rate in Neurological Disorder Drugs Business (2017-2022)
    Figure 48. Bayer Revenue Growth Rate in Neurological Disorder Drugs Business (2017-2022)
    Figure 49. AstraZeneca Revenue Growth Rate in Neurological Disorder Drugs Business (2017-2022)
    Figure 50. Boehringer Ingelheim Revenue Growth Rate in Neurological Disorder Drugs Business (2017-2022)
    Figure 51. Teva Pharmaceutical Revenue Growth Rate in Neurological Disorder Drugs Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
GlaxoSmithKline
Merck & Co.
Bayer
AstraZeneca
Boehringer Ingelheim
Teva Pharmaceutical
Frequently Asked Questions
Neurological Disorder Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neurological Disorder Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neurological Disorder Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports